Endothelin-1 significantly increased number of specific high-affinity 1,4-dihydropyridine (DHP) binding sites photolabelled on vascular smooth muscle cells with (-)-[3H]-azidopine

Physiological Research

Volumn 45, Issue 1, 1996, Pages 51-58

  Drimal J ^a   Koprda, V ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

Author keywords

( ) 3H azidopine; dihydropyridine receptor; endothelin 1; ligand binding; photoaffinity labelling; S (+) niguldipine; staurosporine; vascular smooth muscle

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; AZIDOPINE; CALCIUM; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; ENDOTHELIN 1; ISRADIPINE; MAGNESIUM; NIFEDIPINE; NIGULDIPINE; NITRENDIPINE; STAUROSPORINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; RAT; VASCULAR SMOOTH MUSCLE;

AFFINITY LABELS; ANIMALS; AORTA, THORACIC; AZIDES; BINDING SITES; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CALCIUM CHANNELS, L-TYPE; CELLS, CULTURED; DIHYDROPYRIDINES; ENDOTHELIN-1; ENZYME INHIBITORS; HUMANS; KINETICS; MUSCLE, SMOOTH, VASCULAR; PROTEIN KINASE C; RATS; STAUROSPORINE;

EID: 0029897811     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BEAM K.G., ADAMS B.A., NIIDOME S., NUMA, TANABE T.: Function of a truncated dihydropyridine receptor as both voltage sensor and calcium channel. Nature 360: 169-171, 1992.
2. BRADFORD M.M.: A rapid and sensitive method for the quantification of microgram quantities of protein dye binding. Anal. Biochem. 72: 248-253, 1976.
3. 2+ channel antagonists. Trends Pharmacol. Sci. 13: 256-262, 1992.
4. DŘÍMAL J.: Heterogeneity of calcium channel agonist binding sites in the coronary artery. Gen. Physiol. Biophys. 7: 135-142, 1988.
5. DŘÍMAL J.: Regulation of beta-adrenergic receptors and calcium channels in cultured human embryonal smooth muscle cells. Gen. Physiol. Biophys. 8: 341-350, 1989.
6. DŘÍMAL J.: Modulation of high affinity phenylalkylamine binding sites on cultured human embryonal vascular smooth muscle cells. Gen. Physiol. Biophys. 11: 555-565, 1992.
7. 3H]-azidopine. Gen. Physiol. Biophys. 13: 137-148, 1994.
8. 3H]azidopine on cultured monkey renal cells. Meth. Find. Exp. Clin. Pharmacol. 16: 397-404, 1994.
9. 3H]azidopine. FEBS Lett. 169: 112-118, 1984.
10. GALIZZI J.P., FOSSET M., VAN RENTHERGHEM C., LAZDUNSKI M.: Regulation of calcium channels in aortic muscle cells by protein kinase C activators (diacylglycerol and phorbol esters and by peptides (vasopressin and bombensin) that stimulate phosphoinositide breakdown. J. Biol. Chem. 262: 6947-6950, 1987.
11. HU S., KIM H.S, LAPPE R.W., WEBB R.L.: Coupling of endothelin receptors to ion channels in rat glomerular mesangial cells. J. Cardiovasc. Pharmacol. 22 (Suppl. 8): S149-S153, 1993.
12. + exchange. Biochem. J. 310: 1013-1020, 1995.
13. HUGUET F., BRISAC A.M., DUBAR M., INGRAND P., PIRIOU A.: Endothelin modulates dihydropyridine receptor decreased binding in hippocampal slices from normotensive and spontaneously hypertensive rats. Int. J. Dev. Neurosci. 11: 295-301, 1993.
14. 2+ channels. Neuron 12: 1301-1318, 1994.
15. JOUNEAUX C., GOLDSMITH P., HANOUNE J., LOTERSZTAJN S.: Endothelin inhibits the calcium pump and stimulates phosphoinositide phospholipase C in liver plasma membrane via two different G proteins, Gs and Gq. J. Cardiovasc. Pharmacol. 22 (Suppl. 8): S158-S160, 1993.
16. MARKS A.: Calcium channels expressed in vascular smooth muscle. Circulation 86 (Suppl. II): II161-II167, 1992.
17. MOREL N., GODFRAIND T.: Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle. J. Pharmacol. Exp. Ther. 243: 711-716, 1987.
18. MOREL N., GODFRAIND T.: Selective interaction of the calcium antagonist amlodipine with calcium channels in arteries of spontaneously hypertensive rats. J. Cardiovasc. Pharmacol. 24: 524-533, 1994.
19. NAKASHIMA M., VANHOUTTE P.M.: Endothelins and membrane potential of vascular smooth muscle of the canine coronary artery. J. Cardiovasc. Pharm. 22: S229-S231, 1993.
20. 2+ channel alpha subunit (alpha 1 C) expressed in Xenopus oocytes. Biophys. J. 66: 1895-1903, 1994.
21. SANQUINETTI M.C., KASS R.S.: Voltage-dependent block of calcium channel current in the calf cardiac Purkinje fiber by dihydropyridine calcium channel antagonists. Circ. Res. 55: 336-348, 1984.
22. 2+ oscillations and activation of glycogenolysis. J. Clin. Invest. 87: 133±138, 1991.
23. SIMONSON M.S., WANN S., MENE P., DUBYAK G.R., KESTER M., DUNN M.J.: Endothelin-1 activates the phosphoinositide cascade in cultured glomerular mesangial cells. J. Cardiovasc. Pharmacol. 13 (Suppl. 5): S80-S84, 1989.
24. TOYO-OKA T., AIZAWA T., SUZUKI N., HIRATA Y., MIYAGUCHI T., SHIN W.S., YANAGISAWA M., MASAKI T., SUGIMOTO T.: Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation 83: 476-483, 1991.
25. 2+ channel function and drug action. Trends Pharmacol. Sci. 16: 43-49, 1995.
26. WANG Y., POUYSSEGUR J., DUNN M.J.: Endothelin stimulates mitogen activated protein kinase p42 activity through the phosphorylation of the kinase in rat mesangial cells. J. Cardiovasc. Pharmacol. 22 (Suppl 8): S164-S167, 1993.
27. 2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes. Mol. Pharmacol. 35: 541-552, 1989.
28. YANAGISAWA M., KURIHARA H., KIMURA S., TOMOBE Y., KOBAYASHI M., MITSUI Y., YAZAKI Y., GOTO K., MASAKI T.: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
29. ZONG Z.Q., ZHOU J.Y., TANABE T.: Molecular determinants of calcium-dependent inactivation in cardiac L-type calcium channels. Biochem. Biophys. Res. Commun. 201: 1117-1123, 1994.